Dr. Haresh Tharwani, M.D

NPI: 1790869618
Total Payments
$153,027
2024 Payments
$33,102
Companies
34
Transactions
858
Medicare Patients
1,199
Medicare Billing
$286,478

Payment Breakdown by Category

Other$105,680 (69.1%)
Food & Beverage$21,387 (14.0%)
Travel$13,901 (9.1%)
Consulting$11,880 (7.8%)
Education$178.73 (0.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $105,680 59 69.1%
Food and Beverage $21,387 756 14.0%
Travel and Lodging $13,901 34 9.1%
Consulting Fee $11,880 2 7.8%
Education $178.73 7 0.1%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $50,768 233 $0 (2024)
Otsuka America Pharmaceutical, Inc. $50,488 90 $0 (2024)
Alkermes, Inc. $36,250 77 $0 (2024)
Otsuka Pharmaceutical Development & Commercialization, Inc. $3,652 20 $0 (2019)
Neurocrine Biosciences, Inc. $2,860 91 $0 (2024)
Janssen Pharmaceuticals, Inc $1,415 47 $0 (2024)
Teva Pharmaceuticals USA, Inc. $1,123 51 $0 (2024)
ITI, Inc. $921.28 39 $0 (2023)
LivaNova USA, Inc. $803.29 14 $0 (2024)
Neos Therapeutics, LP $709.12 8 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $33,102 291 ABBVIE INC. ($28,352)
2023 $21,541 253 AbbVie Inc. ($18,071)
2022 $6,211 108 ABBVIE INC. ($4,105)
2021 $18,603 73 Alkermes, Inc. ($17,271)
2020 $5,226 23 Alkermes, Inc. ($4,918)
2019 $21,592 28 Alkermes, Inc. ($12,733)
2018 $21,281 43 Otsuka America Pharmaceutical, Inc. ($19,939)
2017 $25,470 39 Otsuka America Pharmaceutical, Inc. ($24,407)

All Payment Transactions

858 individual payment records from CMS Open Payments — Page 1 of 35

Date Company Product Nature Form Amount Type
12/18/2024 LivaNova USA, Inc. VNS THERAPY SYMMETRY MODEL 8103 GENERATOR (Device) Food and Beverage In-kind items and services $25.42 General
Category: Neurology
12/17/2024 LivaNova USA, Inc. VNS THERAPY SYMMETRY MODEL 8103 GENERATOR (Device) Food and Beverage In-kind items and services $103.89 General
Category: Neurology
12/17/2024 LivaNova USA, Inc. VNS THERAPY SYMMETRY MODEL 8103 GENERATOR (Device) Food and Beverage In-kind items and services $30.65 General
Category: Neurology
12/17/2024 LivaNova USA, Inc. VNS THERAPY SYMMETRY MODEL 8103 GENERATOR (Device) Food and Beverage In-kind items and services $14.18 General
Category: Neurology
12/13/2024 Teva Pharmaceuticals USA, Inc. Austedo XR (Drug) Food and Beverage In-kind items and services $14.41 General
Category: Central Nervous System
12/12/2024 Axsome Therapeutics, Inc. Auvelity (Drug) Food and Beverage In-kind items and services $21.27 General
Category: Psychology/Psychiatric
12/10/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $20.56 General
Category: PSYCHIATRY
12/10/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $12.01 General
Category: NEUROSCIENCE
12/09/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $13.12 General
Category: PSYCHIATRY
12/09/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $1.89 General
Category: PSYCHIATRY
12/06/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $19.93 General
Category: PSYCHIATRY
12/06/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $2.40 General
Category: PSYCHIATRY
12/04/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug) Food and Beverage In-kind items and services $28.11 General
Category: Neuroscience
12/03/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $26.35 General
Category: Neuropsychiatry
12/03/2024 Teva Pharmaceuticals USA, Inc. Austedo XR (Drug) Food and Beverage In-kind items and services $8.06 General
Category: Central Nervous System
12/02/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug) Food and Beverage In-kind items and services $21.15 General
Category: Neuroscience
11/27/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $5.62 General
Category: PSYCHIATRY
11/26/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $6.52 General
Category: Neuropsychiatry
11/25/2024 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $16.74 General
Category: CNS
11/22/2024 Tris Pharma Inc Dyanavel XR (Drug) Food and Beverage In-kind items and services $23.22 General
Category: ADHD
11/22/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $1.60 General
Category: NEUROSCIENCE
11/21/2024 E.R. Squibb & Sons, L.L.C. COBENFY (Drug) Food and Beverage Cash or cash equivalent $123.75 General
Category: Psychiatry/Psychology
11/21/2024 E.R. Squibb & Sons, L.L.C. COBENFY (Drug) Food and Beverage Cash or cash equivalent $20.60 General
Category: Psychiatry/Psychology
11/21/2024 E.R. Squibb & Sons, L.L.C. COBENFY (Drug) Food and Beverage Cash or cash equivalent $0.68 General
Category: Psychiatry/Psychology
11/20/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $10.15 General
Category: NEUROSCIENCE

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 7 318 928 $192,421 $70,751
2022 4 114 447 $97,962 $34,533
2021 5 324 1,078 $175,040 $67,152
2020 6 443 1,843 $296,945 $114,043
Total Patients
1,199
Total Services
4,296
Medicare Billing
$286,478
Procedure Codes
22

All Medicare Procedures & Services

22 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 83 309 $77,868 $27,619 35.5%
90833 Psychotherapy with evaluation and management visit, 30 minutes Office 2023 103 431 $59,909 $21,772 36.3%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 21 73 $25,696 $9,447 36.8%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 55 55 $17,985 $6,900 38.4%
90792 Psychiatric diagnostic evaluation with medical services Office 2023 19 19 $7,486 $2,612 34.9%
96132 Evaluation of neuropsychological test, first hour Office 2023 19 20 $2,700 $1,903 70.5%
96138 Administration of psychological or neuropsychological test by technician, first 30 minutes Office 2023 18 21 $777.00 $496.40 63.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 35 177 $44,604 $16,030 35.9%
90833 Psychotherapy with evaluation and management visit, 30 minutes Office 2022 36 202 $28,078 $10,009 35.6%
90792 Psychiatric diagnostic evaluation with medical services Office 2022 32 32 $12,608 $4,477 35.5%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 11 36 $12,672 $4,016 31.7%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 93 476 $85,680 $26,571 31.0%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 86 317 $57,060 $25,037 43.9%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2021 45 47 $8,460 $6,336 74.9%
99231 Subsequent hospital inpatient care, typically 15 minutes per day Facility 2021 61 198 $15,840 $5,911 37.3%
99239 Hospital discharge day management, more than 30 minutes Facility 2021 39 40 $8,000 $3,297 41.2%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2020 112 815 $146,640 $45,243 30.9%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2020 103 472 $84,830 $38,358 45.2%
99231 Subsequent hospital inpatient care, typically 15 minutes per day Facility 2020 90 393 $31,440 $12,063 38.4%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2020 64 71 $12,935 $9,974 77.1%
99239 Hospital discharge day management, more than 30 minutes Facility 2020 53 65 $13,000 $5,372 41.3%
90792 Psychiatric diagnostic evaluation with medical services Facility 2020 21 27 $8,100 $3,033 37.4%

About Dr. Haresh Tharwani, M.D

Dr. Haresh Tharwani, M.D is a Psychiatry healthcare provider based in Cary, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1790869618.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Haresh Tharwani, M.D has received a total of $153,027 in payments from pharmaceutical and medical device companies, with $33,102 received in 2024. These payments were reported across 858 transactions from 34 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($105,680).

As a Medicare-enrolled provider, Tharwani has provided services to 1,199 Medicare beneficiaries, totaling 4,296 services with total Medicare billing of $286,478. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.

Practice Information

  • Specialty Psychiatry
  • Location Cary, NC
  • Active Since 10/25/2006
  • Last Updated 04/25/2024
  • Taxonomy Code 2084P0800X
  • Entity Type Individual
  • NPI Number 1790869618

Products in Payments

  • VRAYLAR (Drug) $50,854
  • ABILIFY MAINTENA (Drug) $44,695
  • ARISTADA (Drug) $35,431
  • INGREZZA (Drug) $2,860
  • REXULTI (Drug) $1,679
  • CAPLYTA (Drug) $1,428
  • VNS THERAPY SYMMETRY MODEL 8103 GENERATOR (Device) $803.29
  • Adzenys XR-ODT (Drug) $690.63
  • SPRAVATO (Drug) $680.73
  • LYBALVI (Drug) $472.19
  • LATUDA (Drug) $420.77
  • INVEGA TRINZA (Drug) $419.73
  • UZEDY (Drug) $387.72
  • Austedo XR (Drug) $360.94
  • AUSTEDO (Drug) $360.02
  • Aristada 441 mg (Drug) $346.51
  • QUVIVIQ (Drug) $325.16
  • INVEGA SUSTENNA (Drug) $314.98
  • HETLIOZ (Drug) $261.43
  • Qelbree (Drug) $223.51

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Psychiatry Doctors in Cary